Cargando…
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource
The NCI-60 human tumor cell line panel has proved to be a useful tool for the global cancer research community in the search for novel chemotherapeutics. The publicly available cell line characterization and compound screening data from the NCI-60 assay have significantly contributed to the understa...
Autores principales: | Morris, Joel, Kunkel, Mark W., White, Stephen L., Wishka, Donn G., Lopez, Omar D., Bowles, Lori, Sellers Brady, Penny, Ramsey, Patricia, Grams, Julie, Rohrer, Tiffany, Martin, Karen, Dexheimer, Thomas S., Coussens, Nathan P., Evans, David, Risbood, Prabhakar, Sonkin, Dmitriy, Williams, John D., Polley, Eric C., Collins, Jerry M., Doroshow, James H., Teicher, Beverly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618733/ https://www.ncbi.nlm.nih.gov/pubmed/37550087 http://dx.doi.org/10.1158/1535-7163.MCT-23-0267 |
Ejemplares similares
-
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
por: LeBlanc, Amy K., et al.
Publicado: (2022) -
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
por: Crawford, Nyree, et al.
Publicado: (2021) -
DNAPK Inhibition Preferentially Compromises the Repair of Radiation-induced DNA Double-strand Breaks in Chronically Hypoxic Tumor Cells in Xenograft Models
por: Jiang, Yanyan, et al.
Publicado: (2021) -
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
por: Wu, Cheng, et al.
Publicado: (2021) -
Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway
por: Zhang, Wei, et al.
Publicado: (2021)